Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.

Literature DB >> 10319066

Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.

L Fabbri¹, B Beghé, G Caramori, A Papi, M Saetta.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-Asthmatic Agents

Year: 1998 PMID： 10319066 PMCID： PMC1745315 DOI： 10.1136/thx.53.9.803

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

71 in total

1. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.

Authors: J E Garrett; G I Town; P Rodwell; A M Kelly
Journal: J Allergy Clin Immunol Date: 1997-08 Impact factor: 10.793

2. The influence of parasympatholytics on the resolution of acute attacks of asthma.

Authors: E R McFadden; N elSanadi; L Strauss; G Galan; L Dixon; C B McFadden; L Shoemaker; L Gilbert; E Warren; T Hammonds
Journal: Am J Med Date: 1997-01 Impact factor: 4.965

3. Cellular infiltration of the airways in asthma of varying severity.

Authors: M Synek; R Beasley; A J Frew; D Goulding; L Holloway; F C Lampe; W R Roche; S T Holgate
Journal: Am J Respir Crit Care Med Date: 1996-07 Impact factor: 21.405

Review 4. Mechanisms of virus induced exacerbations of asthma.

Authors: J M Corne; S T Holgate
Journal: Thorax Date: 1997-04 Impact factor: 9.139

5. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease.

Authors: J A Barberà; J Roca; A Ferrer; M A Félez; O Díaz; N Roger; R Rodriguez-Roisin
Journal: Eur Respir J Date: 1997-06 Impact factor: 16.671

Review 6. Genetic risk factors for chronic obstructive pulmonary disease.

Authors: A J Sandford; T D Weir; P D Paré
Journal: Eur Respir J Date: 1997-06 Impact factor: 16.671

7. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant.

Authors: J P Collet; P Shapiro; P Ernst; T Renzi; T Ducruet; A Robinson
Journal: Am J Respir Crit Care Med Date: 1997-12 Impact factor: 21.405

Review 8. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.

Authors: R C Beveridge; A F Grunfeld; R V Hodder; P R Verbeek
Journal: CMAJ Date: 1996-07-01 Impact factor: 8.262

9. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors: R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal: N Engl J Med Date: 1997-11-13 Impact factor: 91.245

10. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

Authors: J Vestbo; E Prescott; P Lange
Journal: Am J Respir Crit Care Med Date: 1996-05 Impact factor: 21.405

6 in total

Review 1. Pharmacologic treatment of the adult hospitalized asthma patient.

Authors: M L Kreutzer; S Louie
Journal: Clin Rev Allergy Immunol Date: 2001-06 Impact factor: 8.667

Review 2. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?

Authors: S F Paul Man; Don D Sin
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 3. [Chronic obstructive lung disease].

Authors: C Vogelmeier
Journal: Internist (Berl) Date: 2003-06 Impact factor: 0.743